madman
Super Moderator
Investors and health tech innovators — this episode of New to The Street unveils a potential game-changer in joint regeneration. John Lai, CEO of PetVivo, and Linh Le, CEO of Piezobiomembrane, join host Jane King to discuss a groundbreaking new treatment for osteoarthritis that fuses bioelectric nanofiber technology with PetVivo’s regenerative injection platform.
Their collaborative solution mimics the body’s natural bioelectric signals to regrow cartilage without surgery, drugs, or stem cells. Early studies from the University of Connecticut show significant cartilage regeneration in just 2 months, with no adverse side effects. Backed by a new $2M NIH grant, this cell-free, biodegradable therapy could disrupt the $12B+ U.S. joint replacement market — and drastically reduce healthcare costs.